+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID06087120

Study of Circulating Tumor DNA ctDNA to Predict Breast Cancer Response During Neoadjuvant Chemotherapy

Led by Gene Solutions · Updated on 2025-09-23

125

Participants Needed

3

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective observational study to evaluate circulating tumor DNA ctDNA levels in female patients diagnosed with stage II-III HER2-positive or triple negative breast cancer who are scheduled for neoadjuvant chemotherapy. The study aims to determine ctDNA detection rates before, during, and after treatment, and to explore how ctDNA levels and MRI imaging relate to pathological complete response pCR following therapy. Participants will undergo neoadjuvant chemotherapy regimens such as AC-T, AC-TH, TCH, or TCHP, with allowance for changes if clinically necessary. Blood samples for ctDNA analysis will be collected at diagnosis, during treatment, and after therapy, alongside tumor tissue samples. Imaging studies including ultrasound, MRI, CT scans, chest x-rays, and PET-CT will be performed throughout to monitor response and compare with ctDNA findings. During the approximately one-year study period, participants will provide demographic and medical history information and attend routine clinical visits where imaging and laboratory tests will be performed. Researchers will assess ctDNA changes and correlate these with MRI results and pCR outcomes to evaluate the prognostic value of combining ctDNA detection and imaging. Safety monitoring and data collection will continue throughout the follow-up.

CONDITIONS

Brief Title

Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment

Research Team

L

Lan NL Tu, PHD

V

Van T. Phan, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here